DATA SHEET - Medsafe
DATA SHEET NEISVAC-C® Meningococcal group C polysaccharide conjugate vaccine (tetanus toxoid protein conjugate) COMPOSITION Active ingredient: each 0.5mL dose contains 10 micrograms of meningococcal polysaccharide
Download DATA SHEET - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Meningococcal ACWY Vaccine Recommendations …
immunize.orgMeningococcal ACWY . V accine Recommendations by Age an d Risk F actor . footnotes. 1. 5.The minimum interval between doses of MenACWY is 8 . weeks.
Pathogenesis - Neisseria
neisseria.orgPathogenesis, Plenary Review Virulence determinants of meningococci and factors that may determine between the carrier state and invasive disease M Virji Department of Paediatrics, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU,
PASTOREXTM MENINGITIS 25 tests - Bio-Rad
www.bio-rad.compastorextm meningitis 25 tests 61607 61611 61616 61608 61613 61618 61610 61614 61717 detection of soluble antigens and identification of neisseria meningitidis a, c, y/w135, b/e.coli k1, haemophilus influenzae b, streptococcus pneumoniae, streptococcus b
University Health Services Mānoa - hawaii.edu
www.hawaii.edu#1 #2 #3 Human Papillomavirus (HPV) #1 #2 #3 Meningococcal Quadrivalent #1 Serogroup B Meningococcal (MenB) #1 #2 #3 (if needed) Polio
Don’t Be Guilty of These Preventable Errors in …
www.immunize.orgDon’t Be Guilty of These . Preventable. Errors in Vaccine Administration (continued) page 3 of 4. error: Giving two doses of live injectable or nasally
PUBLIC HEALTH SURVEILLANCE BULLETIN - NICD
www.nicd.ac.za1 Volume 15. Issue 2 - August 2017 SURVEILLANCE BULLETIN PUBLIC HEALTH GERMS-SA Annual surveillance report for laboratory-confirmed invasive meningococcal, pneumococcal and Haemophilus influenzae disease,